Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13555ExperimentalSmall molecule
Prajmaline: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Sodium channel protein
- Formula / weight
- C23H33N2O2 · 369.528 g/mol (avg)
- Also known as
- Prajmalium
Resolves to
Clinical / RWD
Structure
InChIKey
UAUHEPXILIZYCU-ALHOSYKFSA-NSMILESCCC[N@@+]12[C@H]3C[C@]45[C@H](O)[C@H]3[C@@H](C[C@H]1[C@@H]4N(C)C1=C5C=CC=C1)[C@H](CC)[C@H]2OWhat you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which companies are running trials of Prajmaline, in which indications and phases, and which of those programs are still active?